Most dermatology practices sell for 4.0x–8.0x SDE or 7.0x–14.0x EBITDA, with valuations typically ranging from $6 million to $12 million for a practice generating $1.5 million in annual SDE. The final multiple depends on six critical operational factors that together determine acquisition attractiveness and purchase price.

Revenue diversification across medical, surgical, and cosmetic segments represents the first major valuation driver. Medical dermatology—treating acne, eczema, psoriasis, and other conditions—provides stable insurance-reimbursed baseline revenue. However, practices that successfully balance medical services with surgical procedures and cosmetic treatments achieve significantly higher valuations. Buyers pay 15–25% more for practices with revenue streams from multiple channels because this reduces reimbursement risk and improves overall profit stability. A practice generating 40% revenue from medical services, 35% from surgical procedures, and 25% from cosmetic treatments typically receives higher valuation offers than one heavily dependent on insurance reimbursements alone. Cosmetic revenue particularly appeals to private equity and strategic buyers, as it typically carries higher margins and recurring patient relationships. Establishing diversified revenue streams before sale substantially increases final acquisition offers.

Provider coverage and organizational structure form the second critical factor in dermatology practice valuations. Single-provider dermatology practices face substantial key-person risk that directly reduces valuations. Buyers worry that if the sole dermatologist leaves or retires, patient relationships and revenue will evaporate immediately. Practices staffed with multiple dermatologists, physician assistants, and nurse practitioners demonstrate superior organizational stability and scalability. A two-provider practice with strong supporting clinical staff commands significantly higher valuations than a solo practitioner, regardless of whether both generate identical revenue. This provider diversification also enables practices to expand patient capacity and geographic service areas post-acquisition, which strategic buyers highly value. Documentation of provider retention agreements further strengthens valuations significantly.

Mohs micrographic surgery capability represents another premium valuation factor. On-site Mohs surgery adds 0.5–1.0x to overall valuations because it generates higher-margin revenue—typically 40–60% gross margins compared to 25–35% for standard medical services. Mohs surgery also strengthens patient referral networks and increases patient loyalty due to superior outcomes for skin cancer treatment. Practices with established Mohs surgeons and dedicated surgical space attract acquisitive buyers specifically seeking to expand their surgical market presence in target regions. Even smaller practices that add Mohs capability before sale often see measurable valuation improvements that exceed the recruitment cost.

Cosmetic service penetration and quality constitute the fourth major valuation component in dermatology practice acquisitions. Injectable treatments and laser procedures generate recurring patient revenue with strong margins and high customer satisfaction. Cosmetic services also appeal to a broader patient demographic than medical dermatology, enabling practices to grow beyond insurance-dependent reimbursements. Practices where cosmetic revenue exceeds 20% of total revenue typically achieve valuations at the upper end of expected ranges. This segment particularly attracts private equity groups and multi-location dermatology networks building aesthetic market share and developing recurring revenue streams. Skilled injectors and established cosmetic patient relationships significantly increase valuations.

Patient volume metrics and retention rates directly influence buyer risk assessment and acquisition price. Daily patient counts, appointment scheduling efficiency, and annual patient retention rates matter enormously because they signal operational excellence and revenue predictability. A practice consistently averaging 45+ patients daily with greater than 90% annual retention demonstrates strong management and market positioning. Use our valuation calculator to benchmark your patient metrics against industry standards and understand how your efficiency compares to acquisition targets. These operational metrics help buyers project post-acquisition revenue stability and integration success.

Facility quality and location infrastructure represent the final critical driver influencing final valuations. Modern, well-maintained clinics with dedicated procedure rooms, advanced diagnostic and treatment equipment, and convenient geographic positioning command higher valuations. Facilities equipped for multiple dermatologic procedures—from basic office visits to surgical Mohs cases to cosmetic treatments—maximize revenue-generating capacity and attract premium buyers. Older facilities requiring significant capital investment to meet current standards reduce valuations substantially. Location matters equally; practices in high-population-density areas with strong demographic indicators for dermatologic services achieve premium valuations compared to underserved markets. For additional insight into healthcare practice valuations more broadly, see our guides on general medical practices and dental practices to understand how operational metrics drive valuations across different healthcare segments. Understanding and optimizing performance across all six drivers positions your dermatology practice as a premium acquisition target commanding top-tier valuation multiples from qualified buyers. Related industries that follow similar consolidation dynamics include Medical Aesthetics / Med Spa.